Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “WM”

86 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 86 results

Early research (Phase 1)WithdrawnNCT04043845
What this trial is testing

ERK 1/2 Signaling in Ibrutinib Resistant B-cell Malignancies

Who this might be right for
Chronic Lymphocytic LeukemiaWaldenstrom MacroglobulinemiaMantle Cell Lymphoma+1 more
Dana-Farber Cancer Institute
Early research (Phase 1)Active Not RecruitingNCT05753501
What this trial is testing

Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies

Who this might be right for
Hematologic Cancer
AbbVie 135
Not applicableLooking for participantsNCT06043011
What this trial is testing

Registry Platform Hematologic Malignancies (RUBIN) - Extension of Tumor Registry Lymphatic Neoplasms

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Diffuse Large B-cell Lymphoma (DLBCL)Follicular Lymphoma (FL)+3 more
iOMEDICO AG 2,950
Testing effectiveness (Phase 2)Active Not RecruitingNCT04624906
What this trial is testing

Bendamustine, Rituximab and Acalabrutinib in Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom Macroglobulinemia
Sunnybrook Health Sciences Centre 63
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07464210
What this trial is testing

Nemtabrutinib, Bortezomib, and Rituximab for WM

Who this might be right for
Waldenstrom Macroglobulinemia
Seoul National University Hospital 19
Testing effectiveness (Phase 2)Study completedNCT01470196
What this trial is testing

Carfilzomib, Rituximab and Dexamethasone in Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia
Dana-Farber Cancer Institute 31
Large-scale testing (Phase 3)Study completedNCT02165397
What this trial is testing

Ibrutinib With Rituximab in Adults With Waldenström's Macroglobulinemia

Who this might be right for
Waldenström's Macroglobulinemia
Pharmacyclics LLC. 181
Testing effectiveness (Phase 2)Study completedNCT00422799
What this trial is testing

Combination Bortezomib and Rituximab in Patients With Waldenstrom's Macroglobulinemia (WM)

Who this might be right for
Waldenstrom's Macroglobulinemia
Dana-Farber Cancer Institute 63
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07791498
What this trial is testing

Teclistamab In Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia
Massachusetts General Hospital 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT04273139
What this trial is testing

Ibrutinib + Venetoclax in Untreated WM

Who this might be right for
Waldenstrom MacroglobulinemiaMYD88 Gene Mutation
Dana-Farber Cancer Institute 45
Large-scale testing (Phase 3)Ended earlyNCT01732913
What this trial is testing

Efficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas

Who this might be right for
Indolent Non-Hodgkin's Lymphomas
Gilead Sciences 295
Not applicableLooking for participantsNCT06203652
What this trial is testing

The Pathogenesis and Prognostic Factors of Lymphoma

Who this might be right for
LymphomaHodgkin LymphomaNon-hodgkin Lymphoma
Shanghai Zhongshan Hospital 2,000
Early research (Phase 1)Ended earlyNCT01078974
What this trial is testing

Pomalidomide, Dexamethasone and Rituximab in Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia
Steven P. Treon, MD, PhD 7
Testing effectiveness (Phase 2)Study completedNCT02677324
What this trial is testing

Study of ABT-199 (GDC-199) In Patients With Relapsed Or Refractory Waldenström Macroglobulinemia

Who this might be right for
Waldenstrom Macroglobulinemia
Dana-Farber Cancer Institute 33
Early research (Phase 1)Not Yet RecruitingNCT07169565
What this trial is testing

Ibrutinib Followed by BR (Bendamustine and Rituximab) as a Time-Limited Therapy for Waldenström Macroglobulinemia

Who this might be right for
Waldenström Macroglobulinemia (WM)
Institute of Hematology & Blood Diseases Hospital, China 21
Testing effectiveness (Phase 2)UnknownNCT05914662
What this trial is testing

Zanubrutinib Plus BR in Newly Diagnosed Symptomatic WM

Who this might be right for
Waldenstrom Macroglobulinemia
Institute of Hematology & Blood Diseases Hospital, China 42
Early research (Phase 1)Looking for participantsNCT06980116
What this trial is testing

Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies

Who this might be right for
Relapsed or Refractory B-cell MalignanciesChronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)Follicular Lymphoma (FL)+4 more
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. 85
Testing effectiveness (Phase 2)Active Not RecruitingNCT05190705
What this trial is testing

Loncastuximab Tesirine in WM

Who this might be right for
Waldenstrom Macroglobulinemia
Shayna Sarosiek, MD 21
Not applicableStudy completedNCT03255837
What this trial is testing

TDCS on Working Memory (WM) in Adults With ASD

Who this might be right for
Autism Spectrum Disorder
NHS Greater Glasgow and Clyde 50
Not applicableActive Not RecruitingNCT06441214
What this trial is testing

Retrospective-prospective Study to Evaluate Treatment Management and Outcomes of Patients With Waldenström's Macroglobulinemia (WM) Treated in Italy According to the Zanubrutinib (Brukinsa®) Compassionate Use Program (CUP) and in Common Practice Following Commercial Approval.

Who this might be right for
Waldenström's Macroglobulinemia (WM)
Fondazione Italiana Linfomi - ETS 212
Next Page